Search Results - "Gsteiger, S."
-
1
Ebola virus disease outbreak in Nigeria: Transmission dynamics and rapid control
Published in Epidemics (01-06-2015)“…Highlights • Nigeria experienced an Ebola outbreak after importation of a case through air travel. • We fit a transmission model to daily numbers of incident…”
Get full text
Journal Article -
2
Simultaneous Confidence Bands for Nonlinear Regression Models with Application to Population Pharmacokinetic Analyses
Published in Journal of biopharmaceutical statistics (01-07-2011)“…Many applications in biostatistics rely on nonlinear regression models, such as, for example, population pharmacokinetic and pharmacodynamic modeling, or…”
Get full text
Journal Article -
3
Systematic Review Of Mathematical Models Predicting Relative Effectiveness
Published in Value in health (01-11-2014)Get full text
Journal Article -
4
Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling
Published in Clinical pharmacology and therapeutics (01-02-2012)“…Our objective was to show, using two examples, that a pharmacokinetic (PK) similarity analysis can be performed using nonlinear mixed‐effects models (NLMEM)…”
Get full text
Journal Article -
5
PCN433 DISCRETE TIME RESTRICTED CUBIC SPLINE MODELS FOR NETWORK META-ANALYSIS OF TIME-TO-EVENT OUTCOMES
Published in Value in health (01-11-2019)Get full text
Journal Article -
6
PND43 Model-based Economic Evaluations of Interventions for Dementia: A Pragmatic Review
Published in Value in health (01-12-2020)Get full text
Journal Article -
7
Disease Progression In Rheumatoid Arthritis: Key Element for Cost-Effectiveness Modelling
Published in Value in health (01-11-2015)Get full text
Journal Article -
8
PRM126 - Disease Progression In Rheumatoid Arthritis: Key Element for Cost-Effectiveness Modelling
Published in Value in health (01-11-2015)Get full text
Journal Article -
9
-
10
NON-PROPORTIONAL HAZARDS. EXTRAPOLATING RELATIVE TREATMENT EFFECTS BEYOND OBSERVED DATA WITH CANCER IMMUNOTHERAPIES
Published in Value in health (01-05-2017)“…OBJECTIVES: The use of extrapolation in cost-effectiveness analysis (CEA) is essential to estimate costs and benefits of treatments over a lifetime. Typically,…”
Get full text
Journal Article -
11
RM4 - Non-Proportional Hazards in Network Meta-Analysis: Efficient Strategies for Model Building and Analysis
Published in Value in health (01-10-2017)Get full text
Journal Article -
12
Non-Proportional Hazards in Network Meta-Analysis: Efficient Strategies for Model Building and Analysis
Published in Value in health (01-10-2017)“…OBJECTIVES: Cancer immunotherapies often show delayed onset ot etftcacy ana long-term survival benefit compared with chemotherapy. This leads to survival data…”
Get full text
Journal Article -
13
Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer's Coordinating Center Uniform Data Set
Published in BMC neurology (14-08-2023)“…Evidence on the relative risk of death across all stages of Alzheimer's disease (AD) is lacking but greatly needed for the evaluation of new interventions. We…”
Get full text
Journal Article -
14
PRM96 - Systematic Review Of Mathematical Models Predicting Relative Effectiveness
Published in Value in health (01-11-2014)Get full text
Journal Article -
15
Oral abstracts 1: Spondyloarthropathies O1. Detecting axial spondyloarthritis amongst primary care back pain referrals
Published in Rheumatology (Oxford, England) (01-05-2012)Get full text
Journal Article